Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice
- 1 February 2004
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 85 (2) , 409-413
- https://doi.org/10.1099/vir.0.19396-0
Abstract
Human immunodeficiency virus type 1 (HIV-1) subtype C is the predominant HIV in southern Africa, and is the target of a number of recent vaccine candidates. It has been proposed that a heterologous prime/boost vaccination strategy may result in stronger, broader and more prolonged immune responses. Since HIV-1 Gag Pr55 polyprotein can assemble into virus-like particles (VLPs) which have been shown to induce a strong cellular immune response in animals, we showed that a typical southern African subtype C Pr55 protein expressed in insect cells via recombinant baculovirus could form VLPs. We then used the baculovirus-produced VLPs as a boost to a subtype C HIV-1 gag DNA prime vaccination in mice. This study shows that a low dose of HIV-1 subtype C Gag VLPs can significantly boost the immune response to a single subtype C gag DNA inoculation in mice. These results suggest a possible vaccination regimen for humans.Keywords
This publication has 30 references indexed in Scilit:
- Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral LoadJournal of Virology, 2003
- Robust Recall and Long-Term Memory T-Cell Responses Induced by Prime-Boost Regimens with Heterologous Live Viral Vectors Expressing Human Immunodeficiency Virus Type 1 Gag and Env ProteinsJournal of Virology, 2002
- Diversity Considerations in HIV-1 Vaccine SelectionScience, 2002
- The past, present and future of HIV-vaccine development: a critical viewDrug Discovery Today, 2002
- Human Immunodeficiency Virus Type 1-Specific Immunity after Genetic Immunization Is Enhanced by Modification of Gag and Pol ExpressionJournal of Virology, 2001
- Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA VaccineScience, 2001
- High efficient production of Pr55gag virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype AAntiviral Research, 2001
- Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeysProceedings of the National Academy of Sciences, 2000
- HIV-1 Gag Proteins: Diverse Functions in the Virus Life CycleVirology, 1998
- Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cellsPublished by Elsevier ,1989